Vol. 71 No. 2 (2025), EXPERT OPINION

Vol. 71 No. 2 (2025)

I St. Petersburg Consensus on Cosmetology in Cancer Patients "White Nights 2024"

EXPERT OPINION

https://doi.org/10.37469/0507-3758-2025-71-2-OF-2311

Published 30.04.2025

Tatiana Yu. Semiglazova

N.N. Petrov National Medicine Research Center of Oncology, St. Petersburg, the Russian Federation

https://orcid.org/0000-0002-4305-6691

Elena R. Araviiskaia

Pavlov First Saint Petersburg State Medical University, St. Petersburg, the Russian Federation

https://orcid.org/0000-0002-6378-8582

Elena V. Filonenko

P.A. Herzen Moscow State Research Institute – a branch of FSBI National Medical Research Radiological Centre of the Ministry of Health of Russia, Moscow, the Russian Federation

https://orcid.org/0000-0001-8506-7455

Alexey I. Bogatenkov

Saint-Petersburg Institute of Beauty "Galaktika", St. Petersburg, the Russian Federation

https://orcid.org/0000-0001-8433-5446

Elizaveta A. Gintovt

Saint-Petersburg Institute of Beauty "Galaktika", St. Petersburg, the Russian Federation

https://orcid.org/0009-0009-4282-8459

Irina A. Koroleva

Medical University "Reaviz", Samara, the Russian Federation

https://orcid.org/0000-0002-1836-0851

Larisa S. Kruglova

"Central State Medical Academy" of the Administrative Department of the President of the Russian Federation, Moscow, the Russian Federation

https://orcid.org/0000-0002-5044-5265

Olga A. Obukhova

N.N. Blokhin National Medical Research Center of Oncology, Moscow, the Russian Federation

https://orcid.org/0000-0003-0197-7721

Alexey V. Samtsov

S.M. Kirov Military Medical Academy, St. Petersburg, the Russian Federation

https://orcid.org/0000-0002-9458-0872

Daria V. Semiglazova

Cosmetology Clinic Candela Clinic, St. Petersburg, the Russian Federation

https://orcid.org/0009-0006-9326-4284

Alexandra M. Stepanova

Federal State Budgetary Institution Federal Research and Clinical Center of Medical Rehabilitation and Balneology of Federal Medical Biological Agency, Moscow, the Russian Federation

https://orcid.org/0000-0001-8085-8645

Elena V. Tkachenko

N.N. Petrov National Medicine Research Center of Oncology, St. Petersburg, the Russian Federation

https://orcid.org/0000-0001-6375-8335

##article.numberofdownloads## 28

##article.numberofdownloads## 0

##article.numberofdownloads## 2

##article.numberofviews## 37

pdf (Русский)

pdf suppl (Русский)

pdf suppl

Keywords

Consensus «White Nights»
cosmetology
cosmetic procedures
cancer patients
oncosmetology
rehabilitation

How to Cite

Semiglazova, T. Y., Araviiskaia, E. R., Filonenko, E. V., Bogatenkov, A. I., Gintovt, E. A., Koroleva, I. A., Kruglova, L. S., Obukhova, O. A., Samtsov, A. V., Semiglazova, D. V., Stepanova, A. M., & Tkachenko, E. V. (2025). I St. Petersburg Consensus on Cosmetology in Cancer Patients "White Nights 2024". Voprosy Onkologii, 71(2), OF–2311. https://doi.org/10.37469/0507-3758-2025-71-2-OF-2311

Abstract

The article presents the results of the voting of the I St. Petersburg Consensus on Cosmetology in Cancer Patients "White Nights 2024" with the participation of oncologists, rehabilitation specialists and dermatologists-cosmetologists. The Consensus was attended by leading Russian experts who voted during a live broadcast on 16 questions relating to hardware, injections and aesthetic cosmetology for cancer patients.

There was 100% agreement that hardware, injection and aesthetic cosmetology procedures in oncology patients should be performed by a dermatologist-cosmetologist only after consultation with the treating oncologist. When treating cancer patients, the same precautions should be taken as for other patients, with particular attention to the presence of immunosuppression, skin toxicity, drug-drug interactions, interactions with existing malignant treatments, and oncological safety.

The experts unanimously recommended against the use of periosteal fillers in patients with malignant neoplasms who have received, are receiving, or are planning to receive osteomodifying agents: bisphosphonates or denosumab for prophylactic or therapeutic purposes, because of the risk of developing osteonecrosis of the jaw. Filler injection is not recommended for patients with malignant neoplasms who have received or may receive immunotherapy (anti-PD1/anti-PDL1 or anti-CTLA4).

The II St. Petersburg Consensus on Cosmetology in Cancer Patients "White Nights 2024" is scheduled for 4 July 2025.

https://doi.org/10.37469/0507-3758-2025-71-2-OF-2311

##article.numberofdownloads## 28

##article.numberofdownloads## 0

##article.numberofdownloads## 2

##article.numberofviews## 37

pdf (Русский)

pdf suppl (Русский)

pdf suppl

References

X Петербургский международный онкологический форум «Белые ночи 2024». 3 июля - 7 июля 2024 года. Автономная некоммерческая научно-медицинская организация «Вопросы онкологии».-URL: https://forum-onco.ru/.

th St. Petersburg International Oncological Forum "White Nights 2024" July 3 - July 7, 2024. Autonomous non-commercial scientific and medical organization "Questions of Oncology".-URL: https://forum-onco.ru/ (In Rus)].

Dreno B., Khosrotehrani K., De Barros Silva G., et al. The role of dermocosmetics in the management of cancer-related skin toxicities: international expert consensus. Supportive Care in Cancer. 2023; 31(12): 672.-DOI: 10.1007/s00520-023-08116-4.

Lee J., Lim J., Park J.S., et al. The Impact of skin problems on the quality of life in patients treated with anticancer agents: a cross-sectional study. Cancer Research and Treatment. 2018; 50(4): 1186-1193.-DOI: 10.4143/crt.2017.435.

Королева И.А., Болотина Л.В., Гладков О.А., et al. Дерматологические реакции. Практические рекомендации RUSSCO, часть 2. Злокачественные опухоли. 2024(14); #3s2: 122-162.-DOI: 10.18027/2224-5057-2024-14-3s2-2-07.-URL: https://www.rosoncoweb.ru/standarts/RUSSCO/2024/2024-2-07.pdf.

[Koroleva I.A., Bolotina L.V., Gladkov O.A., et al. Prevention and treatment of bone tissue in malignant neoplasms. Practical recommendations RUSSCO, part 2. Malignant Tumours. 2024(14); #3s2: 122-162.-DOI: 10.18027/2224-5057-2024-14-3s2-2-07.-URL: https://www.rosoncoweb.ru/standarts/RUSSCO/2024/2024-2-07.pdf (In Rus)].

Миченко А.В., Круглова Л.С., Шатохина Е.А., et al. Дерматологическая токсичность ингибиторов EGFR: патогенетическое обоснование и алгоритм коррекции акнеподобной сыпи. Онкогематология. 2021; 16(4): 50 58.-URL: https://oncohematology.abvpress.ru/ongm/article/view/504/412?locale=ru_RU. [Michenko A.V., Kruglova L.S., Shatokhina E.A., et al. Dermatological toxicity of EGFR inhibitors: pathogenetic rationale and algorithm for correction of acne-like rash. Oncohematology. 2021; 16(4): 50-58.-URL: https://oncohematology.abvpress.ru/ongm/article/view/504/412?locale=ru_RU (In Rus)].

Т.Ю. Семиглазова, Е.Р. Аравийская, Е.В. Ткаченко, et al. Кожная токсичность при использовании противоопухолевых средств, меры коррекции и профилактики. Учебное пособие. СПб.: Издательство ФГБОУ ВО «СЗГМУ им. И.И. Мечникова» Минздрава России, 2019; 64. ISBN 978-5-907184-65-7.

[Skin toxicity when using antitumor agents, correction and prevention measures. Textbook. Semiglazova T.Yu., Araviyskaya E.R., Tkachenko E.V., et al. St. Petersburg: Publishing House of the I.I. Mechnikov NWSMU of the Ministry of Health of the Russian Federation. 2019; 64. ISBN 978-5-907184-65-7 (In Rus)].

Proietti I., Skroza N., Mambrin A., et al. Aesthetic treatments in cancer patients. Clin Cosmet Investig Dermatol. 2021; 14: 1831-1837.-DOI: 10.2147/CCID.S342734.

Aesthetic treatments for the oncology patient. Ed. by Tejero P., Pinto H. First edition published 2021 by CRC Press. 198.-URL: https://www.routledge.com/Aesthetic-Treatments-for-the-Oncology-Patient/Tejero-Pinto/p/book/9781138305571?srsltid=AfmBOorDDMgmzqk4PSwPYwsPY6o5IzowRPhMffp30N9JuB2aPnuq3eZL.

Sauder M., Addona M., Andriessen A., et. al. The role of skin care in oncology patients. Skin Therapy Letters 2020; (Suppl): 1-12.-URL: https://www.skintherapyletter.com/wp-content/uploads/2020/12/STL-Supp-SkinCareOnc-v2-correction.pdf.

Lacouture M.E., Choi J., Ho A., et al. US Cutaneous Oncodermatology Management (USCOM): a practical algorithm. Journal of Drugs in Dermatology. 2021; 20(9): 3ss-s19.-DOI: 10.36849/jdd.6229.

Congiu M., Buttiron Webber T. Educating the cancer patient about the immunotherapy toxicity: a descriptive observational study. Professioni Infermieristiche 2021; 74(4): 262.-DOI: 10.7429/pi.2021.744262b/.

Государственный реестр лекарственных средств.-URL: https://grls.rosminzdrav.ru/GRLS.aspx.

[State Register of Medicines.-URL: https://grls.rosminzdrav.ru/GRLS.aspx (In Rus)].

Клинические рекомендации. Рак молочной железы. Рубрикатор клинических рекомендаций. Министерство здравоохранения Российской Федерации.-URL: https://cr.minzdrav.gov.ru/schema/379_4.

[Clinical guidelines. Breast cancer. Rubricator of clinical recommendations. Ministry of Health of the Russian Federation.-URL: https://cr.minzdrav.gov.ru/schema/379_4 (In Rus)].

Elias P.M. Optimizing emollient therapy for skin barrier repair in atopic dermatitis. Annals of Allergy, Asthma and Immunology. 2022; 128(5): 505-511.-DOI: 10.1016/j.anai.2022.01.012.

Руководство по дерматокосметологии / Под ред. Е.Р. Аравийской и Е.В. Соколовского. СПб.: Фолиант. 2008; 632. ISBN: 978-5-93929-181-1.

[Manual on dermatocosmetology. Ed. by E.R. Araviyskaya and E.V. Sokolovsky. SPb.: Foliant. ISBN: 978-5-93929-181-1 (In Rus)].

Papagni M., Renga M., Mogavero S., et al. The esthetic use of botulinum toxins in cancer patients: providing a foundation for future indications. Toxins 2025 ; 17(1) : 31.-DOI: 10.3390/toxins17010031.

Shaw L., Bazzell A.F., Dains J.E. Botulinum toxin for side-effect management and prevention of surgical complications in patients treated for head and neck cancers and esophageal cancer. J Adv Pract Oncol. 2019; 10(1): 40-52.-URL: https://pubmed.ncbi.nlm.nih.gov/31308987/.

Roelandt P., Coremans G., Wyndaele J. Analgesic injection of botulinum toxin in anal fissures is efficient and can be performed safely in patients actively receiving chemotherapy. Support Care Cancer. 2020; 28(11): 5053-5054.-DOI: 10.1007/s00520-020-05641-4.-URL: https://pubmed.ncbi.nlm.nih.gov/32712827/.

Teymoortash A., Pfestroff A., Wittig A., et al. Safety and efficacy of botulinum toxin to preserve gland function after radiotherapy in patients with head and neck cancer: a prospective, randomized, placebo-controlled, double-blinded phase I clinical trial. PLoS One. 2016; 11(3): e0151316.-URL: https://pubmed.ncbi.nlm.nih.gov/26991494/.

Nam K.E., Kim J.S., Hong B.Y., et al. Botulinum toxin type a injection for neuropathic pain in a patient with a brain tumor: a case report. Ann Rehabil Med. 2017; 41(6): 1088-1092.-DOI: 10.5535/arm.2017.41.6.1088.-URL: https://pubmed.ncbi.nlm.nih.gov/29354587/.

Talotta R., Rucci F., Canti G., Scaglione F. Pros and cons of the immunogenicity of monoclonal antibodies in cancer treatment: a lesson from autoimmune diseases. Immunotherapy. 2019; 11(3): 241-254.-DOI: 10.2217/imt-2018-0081.-URL: https://pubmed.ncbi.nlm.nih.gov/30730275/.

Shachar E., Hasson E., Arzi O., et al. Aesthetics treatment with injectable fillers in patients with cancer: Safety and quality of life during active antineoplastic therapy. Journal of Clinical Oncology. 2024; 42(16_suppl): e23245-e23245.-DOI : 10.1200/jco.2024.42.16_suppl.e23245.

Shamban A. safety and efficacy of facial rejuvenation with small gel particle hyaluronic acid with lidocaine and abobotulinumtoxin. a in post-chemotherapy patients: a phase IV investigator-initiated study. J Clin Aesthet Dermatol. 2014 ; 7(1): 31-6.-URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC3930538/pdf/jcad_7_1_31.pdf.

Hernández B.A., Gómez S.L.V., Galimberti D.R., Galimberti G.N. Reparación con láser y ácido hialurónico de cicatriz facial secundaria por cirugía oncológica. Dermatología CMQ. 2016; 14(4): 284-288.-URL: https://www.medigraphic.com/pdfs/cosmetica/dcm-2016/dcm164e.pdf.

McCleave M.J. Is breast augmentation using hyaluronic acid safe? Aesthetic Plast Surg. 2010; 34(1): 65-8; discussion 69-70.-DOI: 10.1007/s00266-009-9450-9.

Hasson A., Romero W.A. Treatment of facial atrophic scars with Esthélis, a hyaluronic acid filler with polydense cohesive matrix (CPM). J Drugs Dermatol. 2010; 9(12): 1507-9.-URL: https://pubmed.ncbi.nlm.nih.gov/21120258/.

Sung Y., Kim M.H., Cho E. Successful hyaluronic acid filler injection in a chronic myeloid leukemia patient taking imatinib mesylate. J Cosmet Laser Ther. 2019; 21(4): 243-244.-DOI: 10.1080/14764172.2018.1525745.-URL: https://pubmed.ncbi.nlm.nih.gov/30285513.

Багрова С.Г., Басин Е.М., Борзов К.А. et al. Патология костной ткани. Практические рекомендации RUSSCO, часть 2. Злокачественные опухоли 2024; 14(3s2): 48-60.-DOI: 10.18027/2224-5057-2024-14-3s2-2-03.-URL: https://www.rosoncoweb.ru/standarts/RUSSCO/2024/2024-2-03.pdf.

[Bagrova S.G., Basin E.M., Borzov К.A., et al. Prevention and treatment of bone tissue in malignant neoplasms. Practical recommendations RUSSCO, part 2. Malignant Tumours. 2024; 14(3s2): 48-60.-DOI: 10.18027/2224-5057-2024-14-3s2-2-03.-URL: https://www.rosoncoweb.ru/standarts/RUSSCO/2024/2024-2-03.pdf (In Rus)].

Dhaliwal P., Ibad S., Losak D., Cockerell C. A case of granulomatous hypersensitivity reactions to a dermal filler precipitated by PD-1 checkpoint inhibitor therapy. SKIN J Cutan Med. 2021; 5(1) : 41-45.-DOI: 10.25251/skin.5.1.10.-URL: https://skin.dermsquared.com/skin/article/view/940?articlesBySameAuthorPage=3.

Hibler B.P., Yan B.Y., Marchetti M.A., et al. Facial swelling and foreign body granulomatous reaction to hyaluronic acid filler in the setting of tyrosine kinase inhibitor therapy. Journal of the European Academy of Dermatology and Venereology: JEADV. 2018; 32(6): e225.-DOI: 10.1111/jdv.1474.

Meneghello L.P., Schulz D.G., Aita V.H., et al. Granulomatous reaction after facial filler during metastatic melanoma treatment with immunotherapy: a case report. Anais Brasileiros de Dermatologia. 2025; 100(1): 169-193.-URL: https://www.anaisdedermatologia.org.br/en-pdf-S0365059624001909.

Bisschop C., Bruijn M.S., Stenekes M.W., et al. Foreign body reaction triggered by cytotoxic T lymphocyte-associated protein 4 blockade 25 years after dermal filler injection. Br J Dermatol. 2016; 175(6): 1351-1353.-DOI: 10.1111/bjd.14674.-URL: https://pubmed.ncbi.nlm.nih.gov/27086747/.

Аравийская Е.Р., Соколовский Е.В. Фотопротекция в современной дерматологии и косметологии: классические представления и новые сведения. Вестник дерматологии и венерологии. 2013; 89(3): 114-118.-DOI-10.25208/vdv633.-URL: https://vestnikdv.ru/jour/article/view/633.

[Araviyskaya E.R., Sokolovsky E.V. Photoprotection in modern dermatology and cosmetology: classical concepts and new information. Bulletin of Dermatology and Venereology 2013; 89(3):114-118.-DOI: 10.25208/vdv633-URL: https://vestnikdv.ru/jour/article/view/633 (In Rus)].

Далгатова П.О., Зикиряходжаев А.Д., Грушина Т.И., et al. Использование ботулинического токсина типа А для лечения анимационной деформации после одномоментных реконструктивных операций на молочной железе. Вопросы онкологии. 2024; 70(3): 440-449.-DOI: 10.37469/0507-3758-2024-70-3-440-449.

[Dalgatova P.О., Zikiryakhodzhaev A.D., Grushina T.I., et al. The use of botulinum toxin type A for the treatment of animation deformity after simultaneous breast reconstruction. Voprosy Onkologii = Problems in Oncology. 2024; 70(3): 440-449.-DOI: 10.37469/0507-3758-2024-70-3-440-449 (In Rus)].

Найдина К.А., Зикиряходжаев А.Д., Аблицова Н.В., et al. Результаты консервативной терапии капсулярной контрактуры II-III степени по Baker с помощью ботулинического токсина типа А. Вопросы онкологии. 2025; 71 (1): 175-181.-DOI: 10.37469/0507-3758-2025-71-1-175-181.

[Naidina K.A., Zikiryakhodzhaev A.D., Ablitsova N.V., et al. Results of conservative therapy treatment of Baker grade II-III capsular contracture with botulinum toxin type A. Voprosy Onkologii = Problems in Oncology. 2025; 71(1): 00-00.-DOI: 10.37469/0507-3758-2025-71-1-175-181 (In Rus)].

Новиков Р.В., Пономарева О.И., Новиков С.Н., et al. МР-семиотика результатов трансперинеального введения «спейсера» на основе синтетического коллагена животного происхождения для оптимизации лучевого лечения рака предстательной железы. Вопросы онкологии. 2023; 6(69): 1039-1048.-DOI: 10.37469/0507-3758-2023-69-6-1039-1048.

[Novikov R.V., Ponomareva O.I., Novikov S.N., et al. MRI findings of the results of transperineal insertion of a "spacer" based on synthetic collagen of animal origin to optimize radiation treatment of prostate cancer. Voprosy Onkologii = Problems in Oncology. 2023; 69(6): 1039-1048.-DOI: 10.37469/0507-3758-2023-69-6-1039-1048 (In Rus)].

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Most read articles by the same author(s)

Tatiana Y. Semiglazova, Olga I. Ponasenko, Varvara A. Lyaschenko, Sheida R. Abdullaeva, Tatiana I. Kudriashova, Anton A. Krutov, Nadezhda A. Brish, Yuliya V. Alekseeva, Elena V. Tkachenko, Tatiana A. Karavaeva, Vladislav V. Semiglazov, Boris S. Kasparov, Петр Владимирович Krivorotko, Vladimir F. Semiglazov, Late Complications of Chemotherapy and Hormone Therapy in the Cancer: General Weakness, Cognitive Impairment, Peripheral Neuropathy, Treatment-Induced Myeloproliferative Diseases (Part 1) , Voprosy onkologii: Vol. 70 No. 3 (2024)
Vladimir F. Semiglazov, Petr V. Krivorotko, Tatiana Y. Semiglazova, Elena V. Artamonova, Anna S. Artemyeva, Svetlana G. Bagrova, Larisa V. Bolotina, Elena M. Bit-Sava , Alla A. Bozhok, Lubov Yu. Vladimirova, Vera А. Gorbunova, Haykuhi K. Geokchyan-Kzhdryan, Natalia V. Dengina, Ludmila G. Zhukovа, Aziz D. Zikiryakhodjaev, Evgeny N. Imyanitov, Irina V. Kolyadina, Irina A. Koroleva, Asel G. Kudaibergenova, Alexey G. Manikhas, Sergey N. Novikov, Rashida V. Orlova, Ruslan M. Paltuev, Alexander V. Petrovsky, Anastasiia A. Parokonnaia, Sergey M. Portnoj, Grigory A. Raskin, Valerii V. Rodionov, Nikita A. Savelov, Vladislav V. Semiglazov, Marina B. Stenina, Kaldygul K. Smagulova, Daniil L. Stroyakovskiy, Eldar E. Topuzov, Oxana P. Trofimova, Mona A. Frolova, Olga S. Khodorovich, Yuliana S. Shatova, I St. Petersburg International Consensus on the Diagnosis and Treatment of Breast Cancer «White Nights 2024» , Voprosy onkologii: Vol. 70 No. 6 (2024)
Sheyda R. Abdullaeva, Tatiana Yu. Semiglazova, Anna S. Artemyeva, Valentina A. Zagoruiko, Tatiana I. Kudriashova, Olga I. Ponasenko, Boris S. Kasparov, Larisa V. Filatova, Vladislav V. Semiglazov, Petr V. Krivorotko, Vladimir F. Semiglazov, Predictive and Prognostic Role of TILs In Platinum-Based Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer , Voprosy onkologii: Vol. 70 No. 3 (2024)
Gulfia M. Teletaeva, Ekaterina A. Degtiareva, Anna I. Semenova, Tatiana Yu. Semiglazova, Artur Yu. Malygin, Aglaya G. Iyevleva, Evgeniy N. Imyanitov , Molecular Landscape of Colorectal Cancer: Clinical Significance of Typical and Atypical Mutations , Voprosy onkologii: Vol. 70 No. 5 (2024)
Svetlana S. Elkhova, Larisa V. Filatova, Ilya S. Zyuzgin, Stanislav A. Volchyonkov, Irina V. Ishmatova, Anna A. Zverkova, Yuliya A. Nikulina, Leonid A. Kramynin, Evgeniya V. Dobrovolskaya, Tatiana Yu. Semiglazova, Comparison of Stem Cell Mobilization Efficacy with Intermediate Dose Cytarabine Versus Cyclophosphamide or Plerixafor in Poor Mobilizers , Voprosy onkologii: Vol. 70 No. 4 (2024)
Leonid A. Kramynin, Larisa V. Filatova, Margarita S. Motalkina, Ilya S. Zyuzgin, Yuliya A. Nikulina, Svetlana S. Elkhova, Irina V. Ishmatova, Anna A. Zverkova, Stanislav A. Volchyonkov, Evgeniya V. Dobrovolskaya, Nikita S. Kolupaev, Anastasia G. Kolgotina, Alina O. Eliseeva, Tatiana Yu. Semiglazova, Consolidative Radiotherapy in the Treatment of Primary Mediastinal Large B-Cell Lymphoma , Voprosy onkologii: Vol. 71 No. 1 (2025)
Alexey M. Belyaev, Vladimir F. Semiglazov, Sergey S. Bagnenko, Sergey V. Kirichuk, Alexander N. Stukov, Aleksei V. Gulyaev, Sergey N. Novikov, Elena V. Bakhidze, Asel G. Kudaibergenova, Vladislav V. Semiglazov, Nickolay S. Ustimov, Mariia N. Filkovskaia, Maria S. Kobysheva, Tatiana Yu. Semiglazova, The Institute of Oncology during the Great Patriotic War. Dedicated to the 80th anniversary of the Great Victory. , Voprosy onkologii: Vol. 71 No. 2 (2025)
Gulfia M. Teletaeva, Ekaterina A. Degtiareva, Tatiana Yu. Semiglazova, Lilia Sergeevna Baboshkina , Evgeniy N. Imyanitov, Current Treatment Approaches for KRAS-Mutant Metastatic Colorectal Cancer: A Literature Review , Voprosy onkologii: Vol. 71 No. 2 (2025)